In the second half of a two-part interview, Rachel Freedman, MD, MPH, of Dana-Farber Cancer Institute, is joined by colleagues Ludmilla Svoboda, RN, Fabia Federico, and Ariana Vazquez, all of Dana-Farber, to discuss how Dana-Farber’s Patient Navigator Program is helping to ameliorate health disparities among women with breast cancer by putting patients’ needs first. ...
Disparities in Breast Cancer
Advertisement
For people with metastatic cancer, the constant focus on cure can create a sense of isolation from the cancer community.
A study assessed the impact of the COVID-19 pandemic on Black and Hispanic breast cancer (BC) survivors.
Researchers observed that the risk of dying from breast cancer in men with HR-positive cancer increased with cancer stage.
Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk gene mutations.
Dr. Rachel Freedman of Dana-Farber Cancer Institute is joined by colleagues to discuss barriers of cancer in breast cancer.
"Rates of post-mastectomy reconstruction in Asian Americans were much lower than non-Asian Americans.”
Support interventions are needed for managing oral endocrine therapy-related symptoms among Black breast cancer survivors.
Racial disparities exist in the initiation of chemotherapy, with a negative impact on Black women.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
Advertisement
Section Editor
Rachel Freedman, MD, MPHMedical oncologist, clinical researcher | Dana-Farber Cancer Institute
Advertisement
Latest News
